Difference between revisions of "MEDICATION-ADRENALINE"

Latest revision as of 11:31, 1 January 2023

SUMMARY

1. Naturally occurring catecholamine with alpha (vasoconstriction) & beta effects.2. Administer in the setting of cardiac arrest to cause vasoconstriction and to redirect available CO to the myocardium & brain.
3. It raises diastolic pressure thereby improving coronoary perfusion and facilitating defibrillation by improving myocardial blood flow during CPR.
4. Indications: asystole, PEA, pulseless VT/VF, bradycardia unresponsive to atropine.
5. Given IM in the setting of anaphylaxis: 0.5 mg every 15 min.
6. SE: tachycardia, HTN, arrhythmias, tissue necrosis if extravasation occurs, hyperglycaemia.

DOSAGE
7. Administer 1 mg every second loop of CPR (1:10,000 via IV cannula or 1:1000 via central line).
8. Infusion of 1-20 mcg/min in ICU.

@@ Line 1: / Line 1: @@
-[[Topic summary|<h5>'''TOPIC SUMMARY'''</h5>]]
+===== [[Summary Article|'''SUMMARY''']] =====
+. Naturally occurring catecholamine with <i>alpha </i>(vasoconstriction) &amp; <i>beta </i>effects.2. Administer in the setting of cardiac arrest to cause vasoconstriction and to redirect available CO to the myocardium &amp; brain.
+<br/>3. It raises diastolic pressure thereby improving coronoary perfusion and facilitating defibrillation by improving myocardial blood flow during CPR.
+<br/>4. Indications: asystole, PEA, pulseless VT/VF, bradycardia unresponsive to atropine.
+<br/>5. Given IM in the setting of anaphylaxis: 0.5 mg every 15 min.
+<br/>6. SE: tachycardia, HTN, arrhythmias, tissue necrosis if extravasation occurs, hyperglycaemia.
 <br/>
-<div>1. Naturally occurring catecholamine with <i>alpha </i>(vasoconstriction) & <i>beta </i>effects.<div>2. Administer in the setting of cardiac arrest to cause vasoconstriction and to redirect available CO to the myocardium & brain.</div><div>3. It raises diastolic pressure thereby improving coronoary perfusion and facilitating defibrillation by improving myocardial blood flow during CPR.</div><div>4. Indications: asystole, PEA, pulseless VT/VF, bradycardia unresponsive to atropine.</div><div>5. Given IM in the setting of anaphylaxis: 0.5 mg every 15 min.</div><div>6. SE: tachycardia, HTN, arrhythmias, tissue necrosis if extravasation occurs, hyperglycaemia.</div><div><br></div><div>DOSAGE</div><div>7. Administer 1 mg every second loop of CPR (1:10,000 via IV cannula or 1:1000 via central line).</div><div>8. Infusion of 1-20 mcg/min in ICU.</div>
+<br/>DOSAGE
+<br/>7. Administer 1 mg every second loop of CPR (1:10,000 via IV cannula or 1:1000 via central line).
+<br/>8. Infusion of 1-20 mcg/min in ICU.
-==Reference(s)==
-Gale, M., Grantham, H., Morley, P. and Parr, M. (2016). Advanced Life Support Level 1: 3rd Australian Edition. Australian Resuscitation Council.
-<br/>American College Of Surgeons. Committee On Trauma (2012). ATLS : student course manual. Chicago, Ill.: American College Of Surgeons.
 [[Category:Medication]]
 [[Category:Advanced Life Support]]